CarsonAllaria Wealth Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

CarsonAllaria Wealth Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-30	Closed	-$623	–	359
2025 Q1	$623	Hold	30	–	–	﹤0.01%	354
2024 Q4	$706	Sell	30 -213	-88%	-$5.24K	﹤0.01%	335
2024 Q3	$6.22K	Hold	243	–	–	﹤0.01%	295
2024 Q2	$5.71K	Hold	243	–	–	﹤0.01%	284
2024 Q1	$6.99K	Hold	243	–	–	﹤0.01%	271
2023 Q4	$7.97K	Hold	243	–	–	0.01%	228
2023 Q3	$6.77K	Hold	243	–	–	0.01%	234
2023 Q2	$8.28K	Hold	243	–	–	0.01%	234
2023 Q1	$7.31K	Hold	243	–	–	0.01%	232
2022 Q4	$7K	Buy	243 +178	+274%	+$5.65K	0.01%	212
2022 Q3	$2K	Hold	65	–	–	﹤0.01%	272
2022 Q2	$2K	Sell	65 -358	-85%	-$12.5K	﹤0.01%	275
2022 Q1	$19K	Buy	423 +353	+504%	+$16.8K	0.02%	163
2021 Q4	$4K	Buy	+70	New	+$4.84K	﹤0.01%	281

Other funds holding ARKG

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

CarsonAllaria Wealth Management's ARKG Position: Q2 2025 in Review

CarsonAllaria Wealth Management sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2025, closing a stake of 30 shares — an estimated $623 sold.

CarsonAllaria Wealth Management first reported a position in ARKG in Q4 2021 and held it in 14 quarters. The position peaked at $19K in Q1 2022. 216 funds tracked by Wall St. Rank hold ARKG as of Q2 2025.

CarsonAllaria Wealth Management reported no remaining ARK Genomic Revolution ETF position as of Q2 2025 after selling out during the quarter.
CarsonAllaria Wealth Management sold 30 ARK Genomic Revolution ETF shares in Q2 2025, an estimated $623.
CarsonAllaria Wealth Management first reported a position in ARK Genomic Revolution ETF in Q4 2021 and held it in 14 quarters.
CarsonAllaria Wealth Management's ARK Genomic Revolution ETF position peaked at $19K in Q1 2022.
216 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2025.

Based on CarsonAllaria Wealth Management's 13F filing for Q2 2025, filed 24 Jul 2025.